Tech Company Financing Transactions
Evvy Funding Round
On 9/27/2023, Evvy raised $14 million in Series A investment from Left Lane Capital, Amboy Street Ventures and G9 Ventures.
Transaction Overview
Company Name
Announced On
9/27/2023
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series A
Investors
Proceeds Purpose
Vaginal discomfort is a leading reason that women seek healthcare advice in the U.S., with misdiagnosis and recurrence rates higher than 50%.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
169 Madison Avenue 2064
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Undisclosed
Website
Email Address
Overview
Evvy is unlocking precision women's healthcare through novel, overlooked female biomarkers -- starting with the vaginal microbiome. Backed by leading healthcare investors such as General Catalyst, Left Lane Capital, and LabCorp, the Evvy team includes leading OB/GYNs and vaginal microbiome researchers with decades of experience at organizations like UCSF, Stanford, Harvard, Cleveland Clinic, and more. Evvy is one of the fastest growing women's health companies in the US -- enabling us to deliver innovative, high quality care while scaling novel R&D to unlock a new, data-driven future in women's health.
Management Team
Browse more venture capital transactions:
Prev: 9/27/2023: Blacklane venture capital transaction
Next: 9/27/2023: Automera venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs